In the past week, WINT stock has gone down by -36.50%, with a monthly decline of -74.48% and a quarterly plunge of -33.44%. The volatility ratio for the week is 11.25%, and the volatility levels for the last 30 days are 22.74% for Windtree Therapeutics Inc The simple moving average for the past 20 days is -32.57% for WINT’s stock, with a -68.30% simple moving average for the past 200 days.
Is It Worth Investing in Windtree Therapeutics Inc (NASDAQ: WINT) Right Now?
The stock has a 36-month beta value of 0.55. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for WINT is 1.40M, and at present, short sellers hold a 2.57% of that float. On October 02, 2024, the average trading volume of WINT was 1.39M shares.
WINT) stock’s latest price update
The stock of Windtree Therapeutics Inc (NASDAQ: WINT) has decreased by -13.39 when compared to last closing price of 2.39.Despite this, the company has seen a loss of -36.50% in its stock price over the last five trading days. globenewswire.com reported 2024-09-30 that Istaroxime treatment significantly improved systolic blood pressure as well as cardiac output and renal function without increasing heart rate or clinically significant arrythmias
Analysts’ Opinion of WINT
Many brokerage firms have already submitted their reports for WINT stocks, with Ladenburg Thalmann repeating the rating for WINT by listing it as a “Buy.” The predicted price for WINT in the upcoming period, according to Ladenburg Thalmann is $12.25 based on the research report published on June 26, 2020 of the previous year 2020.
WINT Trading at -69.33% from the 50-Day Moving Average
After a stumble in the market that brought WINT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.33% of loss for the given period.
Volatility was left at 22.74%, however, over the last 30 days, the volatility rate increased by 11.25%, as shares sank -35.11% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -41.85% lower at present.
During the last 5 trading sessions, WINT fell by -36.50%, which changed the moving average for the period of 200-days by -84.24% in comparison to the 20-day moving average, which settled at $3.01. In addition, Windtree Therapeutics Inc saw -84.01% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for WINT
The total capital return value is set at -1.28. Equity return is now at value -103.25, with -32.86 for asset returns.
Based on Windtree Therapeutics Inc (WINT), the company’s capital structure generated 0.27 points at debt to capital in total, while cash flow to debt ratio is standing at -3.28. The debt to equity ratio resting at 0.37. The interest coverage ratio of the stock is 354.25.
Currently, EBITDA for the company is -17.46 million with net debt to EBITDA at -0.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.23.
Conclusion
To sum up, Windtree Therapeutics Inc (WINT) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
